SafeCode Drug Technologies
Voice-enabled Drug Administrator
Cyber Security
Non Active, Dec 2018
Company Overview
Snapshot
Founded in January 2010, SafeCode Drug Technologies operates with 1–10 employees. The company is currently in a Pre-Funding stage.
Business overview
SafeCode Drug Technologies develops a patent-pending voice recognition technology designed to prevent unauthorized administration of prescription medication. Its core product features a voice-enabled protector that includes a barcode for patient identification, a drug-name identifier, a computer-readable medium with stored voice templates, a processing unit, and a software application. The company operates in the Cyber Security and Digital Healthcare sectors, serving markets related to clinical workflow and medication security.
Log in to access full profile ›Company Intelligence Q&A
- What is SafeCode Drug Technologies' primary focus?
- SafeCode Drug Technologies focuses on developing voice recognition technology to secure and prevent unauthorized administration of prescription medications.
- What technology does SafeCode Drug Technologies utilize?
- The company utilizes artificial intelligence, specifically voice and speech recognition, as a core technology within its platforms and interfaces.
- What are the key components of SafeCode Drug Technologies' voice-enabled protector?
- The voice-enabled protector includes a barcode for patient identification, a drug-name identifier, a computer-readable medium with stored drug templates, a processing unit, and a software application.
- Which industries does SafeCode Drug Technologies target?
- SafeCode Drug Technologies targets the healthcare and life sciences industries, specifically healthcare providers and patients, with its clinical workflow and identity security solutions.
- When was SafeCode Drug Technologies founded?
- SafeCode Drug Technologies was founded in January 2010.